CirCode
Shanghai
About CirCode
CirCode Bio is an innovative biotechnology company focusing on the development of circular RNA nucleic acid drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $20.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2023)
- Website: circodebio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Medical
Canonical: https://fsome.com/organization/circode-57118 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.